The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers

Effect ofHMGCRVariant Alleles on Low-Density Lipoprotein Cholesterol-Lowering Response to Atorvastatin in Healthy Korean Subjects

(2011) Jae Yong Chung et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose

(2011) Ichiro Ieiri et al.   Pharmacogenetics and Genomics

Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis

(2011) Stephan Riedmaier et al.   Frontiers in Pharmacology

The UGT1A1∗28 polymorphism correlates with erlotinib’s effect on SN-38 glucuronidation

(2010) Yong Liu et al.   EUROPEAN JOURNAL OF CANCER

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations

(2010) Mathew J. Barber et al.   PLoS One

Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins

(2009) Michael J. Knauer et al.   CIRCULATION RESEARCH

Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers

(2009) Katrin Borucki et al.   CLINICAL BIOCHEMISTRY

UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo

(2009) S Riedmaier et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

(2009) J E Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

SLCO1B1Variants and Statin-Induced Myopathy

(2009) Georgirene D. Vladutiu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy

(2008) Y. Akiyama et al.   ANNALS OF ONCOLOGY

Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan

(2008) N Yamamoto et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Statin induced myotoxicity: The lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro

(2008) Ine Blankenberg Skottheim et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES